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CASE PRESENTATION
Case 1: An 11-year-old boy (II-2) was referred for
evaluation of persistent mild proteinuria without
hematuria. His parents and elder brother were negative
for urinalysis. The boy had a history of marked 3þ
proteinuria at birth. Serological tests for infections and
autoantibodies were negative. The nephrotic syndrome
(NS) persisted over the next 2 months (Figure 1), but the
patient entered a partial remission without any
immunosuppressive therapy. He subsequently
experienced 2–3 relapses of nephrotic-range per year in
association with an upper respiratory infection.
Exacerbation of proteinuria usually lasted 1–2 weeks but
spontaneously resolved to the level of 1þ to 2þ .
Biopsies were performed during the patient’s nephrosis at
2 months of age and again when he was in partial
remission at 5 years of age. Physical examination, renal
sonogram, and urogenital studies were normal. Neither
hearing loss nor ophthalmologic abnormalities were
noted. He is currently receiving treatment with
dipyridamole alone.
Case 2: Four-year-old sister (II-3) of case 1 visited our
clinic for evaluation of persistent proteinuria. She first
manifested NS at 10 months of age following an infection.
Similar to her affected brother, she spontaneously
achieved a partial remission once but thereafter repeated
relapses concurrently with respiratory infections. These
relapses typically lasted 7–10 days and proteinuria
remitted to þ / to þ without any therapy. She never
received any medication or renal biopsy.
CLINICAL FOLLOW-UP
Both patients remained in partial remission (persistent mild
proteinuria of less than 100 mg/dl) but still relapsed 2–3 times
per year (Figure 1). The relapses usually followed an upper
respiratory infection and promptly returned to a 1þ to 2þ
level in 1 or 2 weeks, coinciding with resolution of the
infections. The incidence of relapses gradually declined
toward adolescence during the follow-up period. The patients
never experienced generalized edema, even during the
attacks. Neither patient ever received steroids or other
immunosuppressive agents throughout the clinical course.
They displayed normal growth and renal functions have been
preserved.
RENAL BIOPSY FINDINGS
Light microscopic examination of the biopsies from patient
II-2 at the ages of 2 months and 5 years revealed minimal-
change histology (Figure 2a and b). Electron microscopy at 2
months revealed diffuse podocyte foot process effacement
and no other significant ultrastructural abnormalities
(Figure 2c). Direct immunofluorescence demonstrated no
deposition of immunoglobulins (IgG, IgA, and IgM) or
complement (C3, C4, and C1q) (data not shown). Immuno-
fluorescent staining for the a5 and a2 chains of type IV
collagen was normal. Immunohistochemical staining of the
biopsy specimen showed nephrin and podocin in a
continuous linear pattern along the glomerular capillary
loops with intensity that was comparable to that in normal
control tissue, suggesting that foot process integrity was fairly
preserved (Figure 2d and e).
DIFFERENTIAL DIAGNOSIS
A detailed review of the medical records and serological
analysis excludes the possibility of secondary NS because of
congenital infections or environmental insults (allergy, metal
toxicity, insect stings, and so forth). An ultrastructural
evaluation of glomeruli argues against the possibility of
immune-complex-mediated disease (e.g., membranous ne-
phropathy). Familial aggregation and similar clinical features
of early-onset and relapsing NS in the siblings suggest that
the molecular basis may be defects in genes related to the
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glomerular filtration barriers (Table 1).1 Considering the
recessive mode of inheritance in this family, the genes that
encode nephrin,2 podocin,3 and laminin beta 2 chain4 are all
potential candidates. Both nephrin and podocin defects lead
to early-onset NS with minimal-change histology. Podocin
gene mutations generally cause more severe disease, for
example, developing focal segmental glomerulosclerosis and
end-stage renal disease in earlier life. However, the clinical
manifestations per se do not clearly distinguish between the
two genetic defects. Defects in the lamimin beta 2 chain
usually lead to diffuse mesangial sclerosis in combination
with ocular abnormalities. Taken together, in view of a
minimal-change histology, early-onset NS, and the absence of
any extra-renal manifestations (e.g., ocular, urogenital, or
skeletal malformations), nephrin and podocin genes are the
best potential candidates.2,3
GENETIC AND MOLECULAR ANALYSIS
Linkage analysis demonstrated that this family was possibly
linked to NPHS1 on 19q13 (logarithm of odds score is 0. 425
at D19S220) (Figure 3a) but not to NPHS2 on 1q25-31
(logarithm of odds score is 6.274 at D1S218). We therefore
proceeded to sequence NPHS1 and revealed that the
patients are compound heterozygotes for two novel, non-
conserved missense mutations: C265R and V822M. The
cysteine and valine are evolutionarily conserved across
species, suggesting that these two amino-acid residues play
important roles in nephrin protein structure and function.
Restriction fragment length polymorphism analysis revealed
that mutations segregate in the autosomal-recessive mode
(Figure 3b and c).
To further explore the mechanism of NS, we examined the
cellular localization of the two protein variants (C265R and
V822M) in transfected COS-7 cells. Wild-type nephrin
localized to the cell surface. In contrast, C265R mutant
protein exhibited very limited cell-surface expression and was
predominantly trapped within the endoplasmic reticulum.
The V822M variant protein reached the plasma membrane
although some partial trapping in the endoplasmic reticulum
was observed (Figure S1). The size of puncta on the plasma
membrane following antibody cross-linking reflects the
ability of the surface molecules to oligomerize.5 Upon
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Figure 1 | Affected siblings reveal a similar clinical course of early-onset, mild persistent proteinuria with occasional relapses. Case 1
(II-2), an 11-year-old boy, delivered at 39 weeks gestation with a birth weight of 2920 g and placenta weight of 830 g, had marked proteinuria
at birth. Case 2 (II-3), 4-year-old younger sister of Case 1, first manifested NS at 10 months of age. Their typical laboratory data (a, d) at onset of
NS, (b, e) during relapse, and (c, f) in partial remission are shown. In both cases, the relapses usually followed upper respiratory infections
(arrows), lasted 1 or 2 weeks, and did not require any immunosuppressive therapy. Biopsies were performed twice in Case 1 at the ages
of 2 months and 5 years (arrowheads), but were never performed in Case 2.
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cross-linking, cell-surface wild-type nephrin exhibited dis-
crete large punctuate staining, whereas transfected V822M
exhibited a fine granular pattern, suggesting impairment of
lateral oligomerization of V822M mutant protein.
DISCUSSION
Molecular mechanisms of familial NS
Recent genetic studies of familial NS have identified several
disease causing genes (Table 1) and have improved our
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Figure 2 | Renal history and immunohistochemistry. Light microscopy shows a normal-appearing glomerulus (periodic acid-Schiff stain,
original magnification (a)  100; (b)  400). Representative renal histology in patient II-2 at the age of 5 years, during partial remission, is
shown. Capillaries are patent and glomerular basement membrane appears normal in thickness, contour, and texture. The interstitium, renal
tubules, and vessels are normal. (c) Electron micrography when the patient had overt NS at the age of 2 months, discloses a normal-appearing
glomerular basement membrane and no electron-dense deposits, excluding a primary basement membrane defect or immune complex
disease (original magnification  2000). A majority of foot processes are diffusely effaced. (d, e) Staining of nephrin and podocin reveals a
continuous linear pattern along the capillary loops (original magnification  400). A biopsy specimen from patient II-2 at the age of 5 years is
stained with (d) a monoclonal anti-nephrin antibody (50A9)1,20 and (e) a polyclonal anti-podocin antibody. Materials and Methods are provided
as Supplementary Information.
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understanding of clinical entities and the underlying mechan-
isms. Both autosomal-dominant and recessive forms of disease
have been reported. Generally, the recessive form is early-onset
and progresses to end-stage renal disease early in life, whereas
the dominant form is late-onset and progresses slowly. Based
on the mechanisms underlying the breakage of the filtration
barrier, familial NS can be categorized into five classes:
disruption of the slit diaphragm (SD) assembly, altered
podocyte homeostasis due to abnormal calcium influx,
unstable cytoskeletal scaffold for the podocyte foot process,
glomerular basement membrane abnormalities, and transcrip-
tional dysregulation of glomerular development (Table 1). We
speculated that the phenotypes of the present cases – recessive,
early-onset, benign minimal change histology – are due to
either nephrin or podocin defects. As the clinical phenotype by
itself cannot distinguish between the two molecular defects, we
performed genetic analysis for differential diagnosis.
After linkage exclusion of podocin, we found that the
patients harbored two mutations in NPHS1, a causative gene
of autosomal-recessive Finnish-type congenital nephrotic
syndrome (CNF),2 which typically leads to refractory heavy
proteinuria within the first 3 months of life. Nephrin, a
member of the Ig superfamily, is a major structural
component of the SD.1 The six N-terminal Ig domains of
opposing nephrin molecules are positioned in antiparallel
manner and form inter-digitating assemblies that bridge over
the adjacent foot processes.6 The two mutations of Fin-major
(nt121delCT) and Fin-minor (R1109X) are highly prevalent
(490%) in the Finnish population and generally cause severe
early-onset phenotypes. More than 70 mutations so far
reported in CNF patients worldwide include various types of
mutations, that is, missense, mutations occurring at a
splicing site or promoter, small deletions, and insertions. In
view of a growing catalog of NPHS1 mutations, researchers
Table 1 | Clinical features and molecular mechanisms of familial NS
Protein Locus Gene Inheritance Clinical features OMIM References
I. Disruption of the
SD complex
Nephrin 19q13.1 NPHS1 AR Congenital NS of the Finnish type;
typically develop refractory NS within
the first 3 months of life and progress
to ESRD in 2 or 3 years of age; some
mild cases have been observed as in
this study
256300 2
Podocin 1q25–31 NPHS2 AR Steroid resistant NS; early-onset of NS
(MCNS/FSGS) and progression to ESRD
in childhood and adolescence
604766 3
II. Altered podocyte
homeostasis due to
dysregulation of
Ca influx
TRPC6 11q21–22 TRPC6 AD FSGS; onset of proteinuria in
adolescence and early adulthood.
Progression to ESRD after the fourth
decade
603652 15
III. Unstable cytoskeletal
scaffold for the
podocyte foot process
a-Actinin-4 19q13 ACTN4 AD FSGS; onset of proteinuria in
adolescence and early adulthood.
Progression to ESRD in the fifth decade
604638 16
IV. Defective GBM
structure
Laminin b2 3p21 LAMB2 AR Pierson syndrome; onset of NS soon
after birth and early progression to
ESRD. Typically complicated with
ophthalmologic malformations
(microcornia)
609049 4
V. Dysregulation of
early glomerular
development
WT1 11p13 WT1 Sporadica Denys–Drash syndrome and Frasier
syndrome; DMS or FSGS occur in
combination with Wilms tumor and/or
urogenital abnormalities
194080 17
LMX1B 9q34.1 LMX1B AD Nail-patella syndrome; NS occurs in
childhood accompanied with skeletal
and nail malformation
161200 18
Phospholipase
C, epsilon-1
(PLCe1)
10923.32–24.1 NPHS3
PLCE1
AR Truncating mutations lead to early-
onset of NS (DMS) and progression to
ESRD by 5 years of age
Missense mutations display late-onset
of NS (FSGS) and progression to ESRD
in later childhood
Some patients respond to the
immunosuppressive therapy
608414 19
AD, autosomal dominant; AR, autosomal recessive; DMS, diffuse mesangial sclerosis; ESRD, end stage renal disease; FSGS, focal segmental glomerulosclerosis; GBM,
glomerular basement membrane; MCNS, minimal change nephrotic syndrome; NS, nephrotic syndrome; SD, slit diaphragm.
aThe patients mostly appear in sporadic but some cases in a dominant transmission have been reported.
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increasingly recognize that some nephrin variants could cause
a mild NS phenotype.7,8
Molecular mechanism of proteinuria in Case 1 and 2
Case 1 and 2 are both compound heterozygous for nephrin
variants, manifested NS in the first year of life, and had
persistent proteinuria of at least mild to moderate degree
(þ to þ þ on the dipstick) during the remission state. Such
phenotypes are in contrast with the typical clinical features of
CNF, where patients only rarely enter spontaneous remission
and usually progress to end-stage renal disease during the
second and third year of life. The mild phenotypes of Case 1
and 2 reflect that they have a nearly normal filtration barrier,
thereby allowing only moderate urinary protein loss. This
relatively subtle impairment in barrier function is in part
due to the types of mutations (missense variants) and
the degree of resultant misfolding in the mutant proteins.
The obligatory carriers of the respective mutations lack any
urinary abnormalities. The observation indicates that these
variants are insufficient in a heterozygous state to cause
structural damage but lead to overt barrier dysfunction when
homozygous. Consistent with the mild phenotypes, immuno-
histochemistry of the renal biopsy specimens demonstrated
that nephrin and podocin are expressed in a continuous
linear pattern along the capillary lumen in almost normal
abundance, similar to that observed in normal controls,
thereby indicating that foot process integrity is fairly well
preserved. The results of expression studies in COS-7 cells
(Figure S1) provided insights into how these mutations
affected SD integrity. The C265R mutation disrupts forma-
tion of a disulfide bond within the third Ig domain resulting
in the endoplasmic reticulum retention phenotype, thereby
suggesting that the reduced partitioning of C265R in SD
assembly is responsible for the proteinuria. In contrast,
V822M appears to be a considerably milder variant than
C265R, as most of the V822M molecules reach the plasma
membrane. Antibody cross-linking experiments, however,
revealed that the V822M variant likely exhibits an impaired
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Figure 3 | Genetic analysis of cases 1 and 2. (a) Pedigree and linkage analysis on the NPHS1 locus. The parents and one healthy brother (II-1)
have no urinary abnormalities. There was no consanguinity. Ideogram of chromosome 19q13 surrounding the NPHS1 locus and the four
flanking microsatellite markers are shown. Affected individuals are indicated by filled symbols, and unaffected individuals are indicated by open
symbols. The putative disease-associated alleles are indicated by blackened boxes. Logarithm of odds score of 0.425 at D19S220 is only
suggestive of linkage to NPHS1. *Haplotypes of unknown chromosomal phase due to uninformative markers. (b) Mutations segregate in
the recessive mode. Patients are compound heterozygotes for a maternal (C265R) and paternal allele (V822M). The presence of C265R and
V822M is confirmed by digesting the polymerase chain reaction products with HhaI and FokI, respectively, as both mutations create a new
restriction digestion site in the polymerase chain reaction fragments. The lower-shifted bands represent the digested fragments resulting from
mutant alleles (arrowhead; wild-type; arrow; mutant allele). The two variants were absent in 74 control chromosomes, suggesting that the
nucleotide changes are not merely common polymorphisms but pathogenic mutations. (c) Topology model and localization of mutations.
A cysteine residue at position 265 resides at the site forming a disulfide bond in Ig domain 3. A valine residue at position 822 lies in the spacer
region between Ig domains 7 and 8. The cysteine (red arrowhead) and valine (green arrowhead) residues are evolutionarily conserved across
other distinct species. The amino-acid sequence that constitutes an Ig domain is underlined.
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ability to cluster in the plasma membrane. A proposed
structural model of the SD is that antiparallel trans
interaction of opposing nephrin ecto-domains (Ig 1–6)
constitutes the core structure of the SD, which connects
neighboring foot processes. As Ig molecules on the cell
surface are usually associated with each other with only weak
affinity, the formation of a large cluster through interaction
with other partners (e.g., Neph1) and/or self-oligomerization
of nephrin is necessary to form the stable backbone of the
SD.1,6 Clustering of nephrin is implicated in nephrin
signaling because it facilitates recruitment of signaling
adaptors and effectors such as CD2AP, fyn, and Nck9–12 via
raft-mediated mechanisms, thereby ensuring a more stable
anchorage of nephrin to the actin cytoskeleton.
Currently, the data are inadequate to support clearcut
recommendations regarding management of the mild
persistent proteinuria with frequent relapses as in the present
cases. The relapse occurs in more than two-thirds of children
with idiopathic NS and nearly 50% becomes frequent
relapsers. Wingen et al.13 reported that 10–23% of relapses
remitted spontaneously in childhood onset NS but the
molecular mechanism has not yet been clarified. In our cases,
we could speculate that infections resulted in the productions
of some lymphokines and/or other molecules that challenged
the integrity of the permeability barrier and that the nephrin
mutants failed this challenge, thereby leading to proteinuria.
Neither patient ever received steroids or other immuno-
suppressive agents. Patient II-2 has recently been treated
with dipyridamole to reduce the proteinuria, presumably
through action of glomerular hemodynamics. There have
been no randomized trials to evaluate the renal outcome
of patients with persistent mild proteinuria receiving
antiproteinuric agents. Other empirical approaches
using angiotensin-converting enzyme inhibitor or indo-
methacin have been reported for CNF.14 Evaluation of the
efficacy must await a long-term follow-up and further clinical
trials.
Our observations indicate that allelic heterogeneity of
NPHS1 affects the integrity of the SD to a varying extent and
leads to a spectrum of disease severities. The data point to a
need for careful evaluation of similar cases to clarify the extent
to which clinical relapses of minimal change NS patients are
ascribed to specific susceptibilities of the SD. An increased
molecular understanding of SD integrity will facilitate the
prediction of its weaknesses and potential therapeutic
responses, thereby enabling clinicians to avoid unnecessary
steroid therapy and optimize therapeutic regimens.
In summary, minimal change NS disorder generally occurs
sporadically. Patients show a variety of phenotypes with
respects to onset, severity, and prognosis of proteinuria,
reflecting multiple etiologies. In some cases, the genetic
factors having mild biological effects – missense nephrin
variants in these cases – are involved as a predisposing factor
to proteinuria. Genetic diagnosis and a better understanding
of the molecular mechanisms that underlie NS will improve
treatment for nephrotic patients.15–19
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